AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
22
Frequently Asked Questions
What is Market Cap of AN2 Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. AN2 Therapeutics Inc market cap is $35.25M.
What is the 52-week high for AN2 Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. AN2 Therapeutics Inc 52 week high is $1.68 as of October 02, 2025.
What is the 52-week low for AN2 Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AN2 Therapeutics Inc 52 week low is $0.975 as of October 02, 2025.
What is AN2 Therapeutics Inc stock price today?
AN2 Therapeutics Inc stock price today is $1.29.
What was AN2 Therapeutics Inc stock price yesterday?
AN2 Therapeutics Inc stock price yesterday was $1.27.
What is the PE ratio of AN2 Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. AN2 Therapeutics Inc’s P/E ratio is -1.03.
What is the Price-to-Book ratio of AN2 Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. AN2 Therapeutics Inc P/B ratio is 0.5130.
What is the 50-day moving average of AN2 Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AN2 Therapeutics Inc 50-day moving average is $1.17.
